Skip to main content
. 2016 Jun 15;11(6):e0155204. doi: 10.1371/journal.pone.0155204

Table 2. Profile of hypertensive patients at the start of the Pharmaceutical Care.

Sociodemographic Profile Cardiovascular Risk Profile
   n (104) %     n (104) %
Sex Obesity*(BMI ≥30 Kg/m2) Yes 56 53,9
Male 26 25,0 No 48 46,2
Female 78 75,0
Age
30–40 years 2 1,9 Dyslipidemia Yes 28 26,9
41–59 years 35 33,7 No 76 73,1
>60 years 67 64,4
Skin Color
White 58 55,8 Family History Yes 14 13,5
Black 8 7,7 No 90 86,5
Mixed 38 36,5
Education
Iliterate 8 7,7 Smoking Yes 5 4,8
Primary Education 75 72,1 No 99 95,2
High School 17 16,3
University 4 3,9
Ocupational Activity 71 68,3 Diabetes Yes 19 18,3
Family Income No 85 81,7
up to 1 MW 7 6,7
>1–2 MW 26 25,0
>2–3 MW 29 27,9 Waist Circumference* Changed 84 80,8
>3–5 MW 32 30,8 Not Changed 20 19,2
>5 MW  10 9,6        

* Source: VI Brazilian Guidelines on Hypertension (2010); BMI = Body Mass Index; Changed waist circumference values greater than 102 cm for men and 88 cm for women were considered; MW = Minimum Wage, household income was classified according to Brazilian Institute of Geography and Statistics—IBGE.